Medical Director, Division of Surgical Oncology, Memorial Cancer Institute
Christopher Gannon, MD, FACS, is a board-certified, fellowship-trained surgeon specialized in surgical oncology with expertise in cancers of the liver, bile ducts and pancreas. Dr. Gannon also provides surgical care for cancers of the gastrointestinal tract, soft tissues and skin. In addition to malignancies, Dr. Gannon provides comprehensive care for benign diseases of the liver, bile ducts and pancreas, including cysts, stones and biliary reconstruction. In order to treat these conditions, a minimally invasive approach is utilized whenever feasible, including the da Vinci robotic surgical system.
Dr. Gannon received his medical degree in 1998 from Columbia University College of Physicians and Surgeons in New York, New York, after completing his undergraduate education at Yale University. He completed his general surgical residency in 2004 at the University of Maryland Medical Center in Baltimore, Maryland. He also completed fellowship training in surgical oncology in 2007 at the University of Texas MD Anderson Cancer Center in Houston, Texas. He is a diplomate of the American Board of Surgery and a fellow of the American College of Surgeons. Dr. Gannon has published extensively in prominent scientific and medical journals. In addition, he has been invited to present his research findings at national and international surgical conferences.
Dr. Gannon served as an assistant professor of surgery and director of the liver tumor study group in the Division of Surgical Oncology at the Cancer Institute of New Jersey, Robert Wood Johnson Medical School, from 2007 to 2011. He then served as director of surgical oncology at Capital Surgical Group of Capital Health in both Hopewell and Trenton, New Jersey, from 2011 to 2015.
In January 2016, Dr. Gannon joined Memorial Cancer Institute and Memorial Physician Group as Medical Director of the Division of Surgical Oncology.